| |
|
|
|
Vbi Vaccines Inc CS  
|
|
3.21 0.05 (0.02%) |
09-16 16:00 |
|
Open: |
3.14 |
Pre close: |
3.16 |
Target:
|
3.97
|
|
High: |
3.215 |
Low: |
3.09 |
Resistance:
|
3.40
3.81
|
|
Volume: |
1,082,337 |
Market Cap: |
816M |
Support:
|
2.73
2.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.19
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
3.31  |
Signal(12,26,9): |
0.05 |
|
MA(100): |
3.26 |
Stochastic Oscillator |
%K(14,3):
|
12.14 |
|
MA(250): |
3.15 |
%D(3): |
19.22 |
|
Average Volume(K) |
3-Month: |
8842804
|
52-Week |
High:
|
4.83 |
|
10-Days: |
5733639 |
Low: |
2.07 |
|
RSI |
RSI(14):
|
48.17 |
Change(%): |
-14.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.235 |
Return on Equity (ttm) |
-43.6 |
Shares Out. (M) |
254.20 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-18.9 |
Shares Float (M) |
176.98 |
|
EPS Est. Next Year |
-1.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.27 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-27.5 |
% Held by Institutions |
53.23 |
|
Forward EPS |
-0.460 |
Gross Profit (p.s.) |
-0.032 |
Shares Short (K) |
35220 |
|
Book Value (p.s.) |
0.710 |
EBITDA (p.s.) |
-0.190 |
P/E |
-13.66 |
|
Sales Per Share |
0.004 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.52 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.05 |
P/S |
861.65 |
|
Operating Margin |
-5269.38 |
Levered Free Cash Flow
(M) |
-25.68 |
P/CF |
-17.72 |
|
|
|
|
|
|
